Inspire Medical Systems, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Inspire Medical Systems, Inc. (INSP) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $589.02 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-05-07
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $589.02M.
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $572.51M.
- 2023-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $544.18M.
- 2023-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $529.36M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2024-03-31 | $589.02M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $572.51M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $544.18M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $529.36M 10-Q · filed 2023-11-07 |
| 2023-03-31 | $504.65M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $496.01M 10-Q · filed 2024-05-07 |
| 2022-09-30 | $470.20M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $226.98M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $225.06M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $229.05M 10-Q · filed 2023-11-07 |
| 2021-09-30 | $220.30M 10-Q · filed 2022-11-01 |
| 2021-06-30 | $219.91M 10-Q · filed 2022-11-01 |
| 2021-03-31 | $223.13M 10-Q · filed 2022-11-01 |
| 2020-12-31 | $229.75M 10-Q · filed 2022-11-01 |
| 2020-09-30 | $228.82M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $233.59M 10-Q · filed 2021-11-02 |
| 2020-03-31 | $127.40M 10-Q · filed 2021-11-02 |
| 2019-12-31 | $139.84M 10-Q · filed 2021-11-02 |
| 2019-09-30 | $146.05M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $152.49M 10-Q · filed 2020-11-02 |
| 2019-03-31 | $157.42M 10-Q · filed 2020-11-02 |
| 2018-12-31 | $164.00M 10-Q · filed 2020-11-02 |
| 2018-09-30 | $98.31M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $102.58M 10-Q · filed 2019-11-05 |
| 2018-03-31 | -$4.93M 10-Q · filed 2019-08-06 |
| 2017-12-31 | $1.33M 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |